FDA 483 - Predictable Surgical Technologies - November 18, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Predictable Surgical Technologies in Hebron, KY, a human tissue distributor, revealed significant deficiencies in their quality systems and procedures for handling Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). The firm failed to establish appropriate standard operating procedures for storage, receipt, and distribution of HCT/Ps, lacked a method for tracking distinct identification codes for distributed HCT/Ps, and did not have a comprehensive quality program addressing core CGTP requirements.
- Person
ID · 8ed5c03e-5266-4684-bc6d-e7bd8628222e